文献速递消化内镜消化道肿瘤与早癌

胰高血糖素样肽-1受体激动剂对结肠镜检查肠道准备效果的影响

Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy.
PubMed 文献 · Am J Gastroenterol · 2023-10-19

该回顾性队列研究纳入2021年12月至2022年12月在某大型学术医学中心接受筛查或监测性结肠镜检查的446例患者,其中使用GLP-1RA者265例为病例组,未在3个月内使用GLP-1RA者181例为对照组。控制糖尿病后,对照组平均BBPS显著更高(7.0±1.9 vs 7.5±2.4,P=0.046),病例组BBPS总分<5分比例(15.5% vs 6.6%,P=0.01)及因肠道准备不佳需重复结肠镜比例(18.9% vs 11.1%,P=0.041)均显著更高。

要点

  • 使用GLP-1RA与结肠镜检查肠道准备质量显著降低相关。
  • 病例组BBPS总分<5分比例为15.5%,对照组为6.6%(P=0.01)。
  • 病例组因肠道准备不佳需重复结肠镜比例为18.9%,对照组为11.1%(P=0.041)。

核心结论

  • 使用GLP-1RA与结肠镜检查肠道准备质量统计学显著降低相关,因需重复结肠镜检查的差异而具有额外临床意义。
  • 作者认为,理解可能延迟胃排空的药物对肠道准备质量的累积效应至关重要,以更好地理解门诊结肠镜检查前需采取的适当措施和咨询。

研究设计与样本

  • 回顾性队列研究,纳入2021年12月至2022年12月在某大型学术医学中心接受筛查或监测性结肠镜检查的患者。
  • 共纳入446例患者,其中病例组265例(59%)为结肠镜检查期间因糖尿病或肥胖使用任何GLP-1RA者,对照组181例(41%)为曾处方GLP-1RA但结肠镜检查前3个月内未使用者。
  • 排除使用任何促动力或抗动力药物者及手术报告中未记录BBPS者。
  • 采用独立t检验比较连续变量、χ²检验比较分类变量,并行以糖尿病为协变量的多变量线性回归(连续变量)和多变量逻辑回归(分类变量)。

主要发现

  • 除糖尿病诊断外(P=0.001,病例组糖尿病比例更高),两组基线无统计学显著差异。
  • 控制糖尿病后,对照组平均BBPS显著高于病例组(7.0±1.9 vs 7.5±2.4,P=0.046)。
  • BBPS总分<5分的患者比例病例组显著高于对照组(15.5% vs 6.6%,P=0.01)。
  • 因肠道准备不佳需重复结肠镜的患者比例病例组显著高于对照组(18.9% vs 11.1%,P=0.041)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Inadequate bowel preparation can result in decreased diagnostic accuracy and therapeutic safety of colonoscopy for colon cancer screening. The Boston Bowel Preparation Scale (BBPS) has been used to assess the quality of bowel preparation. Glucagon-like peptide-1 receptor agonists (GLP-1RA) are commonly used medications for diabetes mellitus and obesity that are known to delay gastrointestinal motility. We hypothesized that the use of GLP-1RA would be associated with decreased quality of bowel preparation. METHODS: We performed a retrospective cohort study of patients who underwent screening or surveillance colonoscopy at a large academic medical center between December 2021 and December 2022. We included patients taking any GLP-1RA for diabetes or obesity during colonoscopy defined as our cases, and patients who were prescribed GLP-1RA at one point but not within 3 months of colonoscopy defined as our controls. We excluded patients on any promotility or antimotility agents and those without BBPS recorded on their procedure report. Independent t test assessed statistical differences in the case and control groups to compare the quality of bowel preparation for continuous variables, and the χ 2 test was used for categorical variables. Multivariate linear regression including diabetes as a covariate was also performed for continuous variables, and multivariate logistic regression was performed for categorical variables. RESULTS: A total of 446 patients were included in the study, comprising 265 (59%) cases and 181 controls (41%). There were no statistically significant differences between groups at baseline except for the diagnosis of diabetes ( P = 0.001) with a higher proportion of patients with diabetes in the cases. The mean BBPS was significantly higher in controls (7.0 ± 1.9 vs 7.5 ± 2.4, P = 0.046) when controlling for diabetes. The percentage of patients with a total BBPS score of <5 was significantly higher in cases (15.5% vs 6.6%, P = 0.01). The proportion of patients who required a repeat colonoscopy due to poor bowel preparation was also significantly higher in cases (18.9% vs 11.1%, P = 0.041). DISCUSSION: The use of GLP-1RA was associated with a statistically significantly lower quality of bowel preparation, with additional clinical significance given a notable difference in the need for a repeat colonoscopy. It will be essential to understand the cumulative effect of medications that may delay gastric emptying on the quality of bowel preparation to better understand the appropriate measures and counseling that need to be taken before undergoing outpatient colonoscopies.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Yao R, Gala KS, Ghusn W, et al. Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy. Am J Gastroenterol. 2023. PMID: 37856247. doi:10.14309/ajg.0000000000002564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。